Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00579995 · ClinicalTrials.gov registry record · NA
A Prospective, Randomized TrialComparing Oral N-Acetylcysteine and Intravenous Sodium Bicarbonate
A NA study, sponsored by University of Nebraska.
- Terminated
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT00579995 is a NA study that was terminated before completion, run by University of Nebraska. The registered enrollment target is 41 participants.
The verdict
NCT00579995, a NA study, was terminated before completion, sponsored by University of Nebraska.
- TERMINATED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the efficacy of oral N-acetylcysteine and intravenous sodium bicarbonate for the prevention of Contrast-Induced Nephropathy (CIN) after cardiac catheterization.
Interventions
- DRUG Sodium Bicarbonate
- DRUG Oral N-Acetylcysteine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2005-05-01 |
| Est. Completion | 2010-04-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00579995
The ClinicalTrials.gov registry entry for NCT00579995 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sodium Bicarbonate is the first listed.
NCT00579995 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00579995 about?
NCT00579995 is a clinical study titled "A Prospective, Randomized TrialComparing Oral N-Acetylcysteine and Intravenous Sodium Bicarbonate". The purpose of this study is to compare the efficacy of oral N-acetylcysteine and intravenous sodium bicarbonate for the prevention of Contrast-Induced Nephropathy (CIN) after cardiac catheterization.
What is the current status of trial NCT00579995?
This trial is currently terminated. It is a NA study. The enrollment target is 41 participants. The study started on 2005-05-01. Estimated completion is 2010-04-08.
What interventions are being tested in trial NCT00579995?
The interventions under investigation include: Sodium Bicarbonate (DRUG), Oral N-Acetylcysteine (DRUG).
Who is sponsoring clinical trial NCT00579995?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.